The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Open accessAbstract
Neuroendocrine tumours (NET) of the gastroenteropancreatic system comprise a malignant entity with a low incidence. Only limited information is available on long-term clinical outcome and clinically applicable prognostic factors. We performed a retrospective analysis of a large, well-characterized centre-based patient cohort of 399 patients with histologically proven NET. Data were analysed according to epidemiological, clinical and histopathological characteristics. Detailed survival analyses using the Kaplan-Meier method were performed. Prognostic factors were tested by log-rank testing and independent risk factors were analysed using a Cox regression model. In the studied cohort, primary tumours originated in the fore-, mid- and hindgut in 46.1, 37.1 and 4.5% respectively. Extra-intestinal or unknown primary tumours were present in 8.4 and 10.5% respectively. Distant metastasis was present at initial diagnosis in 69.4%. Most frequent metastatic sites were liver (85%), peritoneal cavity (18%), bones (8%), other intra-abdominal sites (6%) and lungs (4%). Overall, 5- and 10-year survival rates were 78 and 63% respectively. Time to progression after initial diagnosis was significantly shorter in pancreatic as compared with ileal NET. Survival analysis revealed significantly better clinical outcome for primary tumours smaller than 25 mm, absence of metastasis, absence of any clinical symptoms, positive immunohistochemical staining for chromogranin A and a lower Ki67 index. These results were confirmed as independent by multivariate analysis. Therefore, this large retrospective analysis of a well-documented cohort of patients with NET demonstrates several prognostic factors of clinical relevance and wide availability, which should be considered for risk stratification in the management of NET.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationRamage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
THE CLASSIFICATION OF CARCINOID TUMOURS
WILLIAMS, E. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
The Gastroenteropancreatic Neuroendocrine Cell System and Its Tumors: The WHO Classification
KLÖPPEL, G., PERREN, A., & HEITZ, P. U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.002 · Cited by 794
Karzinoide Tumoren des Dunndarms
Oberndorfer, S. (1907) · Medical Entomology and Zoology · Cited by 578
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Self-citationRevised classification of neuroendocrine tumours of the lung, pancreas and gut
Capella, C., Heitz, P. U., H�fler, H., Solcia, E., & Kl�ppel, G. (1995) · Virchows Archiv · doi:10.1007/bf00199342 · Cited by 553
Synaptophysin: a marker protein for neuroendocrine cells and neoplasms.
Wiedenmann, B., Franke, W. W., Kuhn, C., Moll, R., & Gould, V. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.10.3500 · Cited by 496
Self-citationGuidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours
Plöckinger, U., Rindi, G., Arnold, R., Eriksson, B., Krenning, E. P., de Herder, W. W., Goede, A., Caplin, M., Öberg, K., Reubi, J. C., et al. (2004) · Neuroendocrinology · doi:10.1159/000085237 · Cited by 477
Self-citationJournal of Histochemistry and Cytochemistry
(1953) · Nature · doi:10.1038/172232b0 · Cited by 472
Weber, H. C., Venzon, D. J., Lin, J.-T., Fishbein, V. A., Orbuch, M., Strader, D. B., Gibril, F., Metz, D. C., Fraker, D. L., Norton, J. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90124-8 · Cited by 467
Pape, U., Jann, H., Müller‐Nordhorn, J., Bockelbrink, A., Berndt, U., Willich, S. N., Koch, M., Röcken, C., Rindi, G., & Wiedenmann, B. (2008) · Cancer · doi:10.1002/cncr.23549 · Cited by 405
Self-citationHochwald, S. N., Zee, S., Conlon, K. C., Colleoni, R., Louie, O., Brennan, M. F., & Klimstra, D. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.10.030 · Cited by 397
Panzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r · Cited by 363
Rindi, G., Azzoni, C., Rosa, S. L., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., & Solcia, E. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70174-5 · Cited by 354
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
Ramage, J. K., Davies, A. H. G., Ardill, J., Bax, N., Caplin, M., Grossman, A., Hawkins, R., McNicol, A. M., Reed, N., Sutton, R., et al. (2005) · Gut · doi:10.1136/gut.2004.053314 · Cited by 350
Specific Endocrine Tissue Marker Defined by a Monoclonal Antibody
Lloyd, R. V., & Wilson, B. S. (1983) · Science · doi:10.1126/science.6635661 · Cited by 337
Effect of Surgery on the Outcome of Midgut Carcinoid Disease with Lymph Node and Liver Metastases
Hellman, P., Lundström, T., Öhrvall, U., Eriksson, B., Skogseid, B., Öberg, K., Tiensuu Janson, E., & Åkerström, G. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6630-z · Cited by 300
The “Normal” Endocrine Cell of the Gut: Changing Concepts and New Evidences
RINDI, G., LEITER, A. B., KOPIN, A. S., BORDI, C., & SOLCIA, E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.001 · Cited by 297
Pelosi, G., Bresaola, E., Bogina, G., Pasini, F., Rodella, S., Castelli, P., Iacono, C., Serio, G., & Zamboni, G. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90303-2 · Cited by 267
Prognosis and Survival in Patients With Gastrointestinal Tract Carcinoid Tumors
Shebani, K. O., Souba, W. W., Finkelstein, D. M., Stark, P. C., Elgadi, K. M., Tanabe, K. K., & Ott, M. J. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00008 · Cited by 266
Epidemiology and survival in patients with carcinoid disease in the Netherlands
Quaedvlieg, P. F. H. J., Visser, O., Lamers, C. B. H. W., Janssen-Heijen, M. L. G., & Taal, B. G. (2001) · Annals of Oncology · doi:10.1023/a:1012272314550 · Cited by 260
Revised Classification of Neuroendocrine Tumors of the Lung, Pancreas and Gut
Capella, C., Heitz, P. U., Höfler, H., Solcia, E., & Klöppel, G. (1994) · Digestion · doi:10.1159/000201197 · Cited by 186
Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases.
Soga, J. (2003) · PubMed · Cited by 156
Gastrointestinal Carcinoids: Characterization by Site of Origin and Hormone Production
Onaitis, M. W., Kirshbom, P. M., Hayward, T. Z., Quayle, F. J., Feldman, J. M., Seigler, H. F., & Tyler, D. S. (2000) · Annals of Surgery · doi:10.1097/00000658-200010000-00010 · Cited by 142
Pape, U., Böhmig, M., Berndt, U., Tiling, N., Wiedenmann, B., & Plöckinger, U. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.025 · Cited by 137
Self-citationIslet Cell Carcinoma of the Pancreas
Lo, C. Y., van Heerden, J. A., Thompson, G. B., Grant, C. S., Søreide, J. A., & Harmsen, W. S. (1996) · World Journal of Surgery · doi:10.1007/s002689900134 · Cited by 137
Klöppel, G., Heitz, P. U., Capella, C., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900021 · Cited by 128
Öberg, K. (2004) · Acta Oncologica · doi:10.1080/02841860410018502 · Cited by 120
Members of Nordic Ne Tumour Group:, Öberg, K., Astrup, L. B., Eriksson, B. K., Falkmer, S. E., Falkmer, S., Gustafsen, J., Haglund, C., Knigge, U., Vatn, M. H., et al. (2004) · Acta Oncologica · doi:10.1080/02841860410018575 · Cited by 105
Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids
Granberg, D. O., Wilander, E., Stridsberg, M., Granérus, G., Skogseid, B. M., & Öberg, K. (1998) · Gut · doi:10.1136/gut.43.2.223 · Cited by 104
Epidemiology of carcinoid neoplasms in Vaud, Switzerland, 1974–97
Levi, F., Te, V.-C., Randimbison, L., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1394 · Cited by 90
Carcinoids of unknown origin: Comparative analysis with foregut, midgut, and hindgut carcinoids
Kirshbom, P. M., Kherani, A. R., Onaitis, M. W., Feldman, J. M., & Tyler, D. S. (1998) · Surgery · doi:10.1067/msy.1998.93105 · Cited by 73
Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system
Wiedenmann, B., John, M., Ahnert‐Hilger, G., & Riecken, E. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050261 · Cited by 66
Self-citationTreatment of Small Intestinal Neuroendocrine Tumors: Is an Extended Multimodal Approach Justified?
Schindl, M., Kaczirek, K., Passler, C., Kaserer, K., Prager, G., Scheuba, C., Raderer, M., & Niederle, B. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6628-6 · Cited by 35
Low Nuclear Proliferative Activity Is Associated With Nonmetastatic Islet Cell Tumors
Jordà, M., Ghorab, Z., Fernández, G. L., et al. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-196-lnpaia · Cited by 17
Cited by
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Self-citationRecommendations for management of patients with neuroendocrine liver metastases
Frilling, A., Modlin, I. M., Kidd, M., Russell, C., Breitenstein, S., Salem, R., Kwekkeboom, D., Lau, W.-Y., Klersy, C., Vilgrain, V., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70362-0 · Cited by 527
Binderup, T., Knigge, U., Loft, A., Federspiel, B., & Kjaer, A. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1759 · Cited by 489
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Self-citation
Metadata
- Authors
- Pape, U.-F., Berndt, U., Muller-Nordhorn, J., Bohmig, M., Roll, S., Koch, M., Willich, S. N., & Wiedenmann, B.
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2008-09-10
- Volume
- 15
- Issue
- 4
- Pages
- 1083-1097
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2098468148
- Cited by
- 384
- References
- 38
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.